Cameron A J, Ott B J, Payne W S
N Engl J Med. 1985 Oct 3;313(14):857-9. doi: 10.1056/NEJM198510033131404.
We evaluated the risk of adenocarcinoma developing in Barrett's esophagus (esophagus lined with columnar epithelium). Mayo Clinic records were reviewed, and all cases that met predefined histologic criteria for the diagnosis of Barrett's esophagus in 1979 or earlier were included. In 18 of 122 such cases, adenocarcinoma of the esophagus and Barrett's esophagus were diagnosed simultaneously. The status of the remaining 104 cases was determined after a mean interval of 8.5 years. During this time, adenocarcinoma of the esophagus developed in 2 patients, and 24 died from other causes. We conclude that although the incidence of esophageal adenocarcinoma is increased in patients with symptomatic Barrett's esophagus, it does not occur in the majority of such patients.
我们评估了巴雷特食管(内衬柱状上皮的食管)发生腺癌的风险。回顾了梅奥诊所的记录,纳入了所有在1979年或更早符合巴雷特食管诊断的预定义组织学标准的病例。在122例此类病例中,有18例同时诊断出食管腺癌和巴雷特食管。其余104例的情况在平均8.5年的间隔后确定。在此期间,2例患者发生了食管腺癌,24例死于其他原因。我们得出结论,虽然有症状的巴雷特食管患者食管腺癌的发病率有所增加,但大多数此类患者并未发生。